Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariel Endlich-Frazier

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Virology|April 6, 2026
Exploring coronavirus cell entry with functional viromicsVictoria Jefferson, Ariel Endlich-Frazier, Michael Letko
Cell Reports|April 14, 2015
An Intrinsically Disordered Peptide from Ebola Virus VP35 Controls Viral RNA Synthesis by Modulating Nucleoprotein-RNA InteractionsDaisy W Leung, Dominika Borek, Priya Luthra, et al.
Msphere|December 14, 2018
The Human Sodium Iodide Symporter as a Reporter Gene for Studying Middle East Respiratory Syndrome Coronavirus PathogenesisSvetlana Chefer, Jurgen Seidel, Adam S Cockrell, et al.
The Journal of Clinical Investigation|November 15, 2023
Antitumor activity of AZD0754, a dnTGFβRII-armored, STEAP2-targeted CAR-T cell therapy, in prostate cancerPeter Zanvit, Dewald van Dyk, Christine Fazenbaker, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Virology|April 6, 2026
Exploring coronavirus cell entry with functional viromicsVictoria Jefferson, Ariel Endlich-Frazier, Michael Letko
Cell Reports|April 14, 2015
An Intrinsically Disordered Peptide from Ebola Virus VP35 Controls Viral RNA Synthesis by Modulating Nucleoprotein-RNA InteractionsDaisy W Leung, Dominika Borek, Priya Luthra, et al.
Msphere|December 14, 2018
The Human Sodium Iodide Symporter as a Reporter Gene for Studying Middle East Respiratory Syndrome Coronavirus PathogenesisSvetlana Chefer, Jurgen Seidel, Adam S Cockrell, et al.
The Journal of Clinical Investigation|November 15, 2023
Antitumor activity of AZD0754, a dnTGFβRII-armored, STEAP2-targeted CAR-T cell therapy, in prostate cancerPeter Zanvit, Dewald van Dyk, Christine Fazenbaker, et al.
Pageof 1